We are live on ! Find out more
ESPR

Esperion Therapeutics
ESPR

Delisted

ESPR was delisted on the 10th of July, 2026.

84 hedge funds and large institutions have $398M invested in Esperion Therapeutics in 2014 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 28 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,167% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 3

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

193% more capital invested

Capital invested by funds: $136M → $398M (+$262M)

133% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 12

68% more funds holding

Funds holding: 5084 (+34)

23% more call options, than puts

Call options by funds: $2.82M | Put options by funds: $2.29M

Holders
84
Holders Change
+34
Holders Change %
+68%
% of All Funds
2.24%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
38
Increased
28
Reduced
12
Closed
3
Calls
$2.82M
Puts
$2.29M
Net Calls
+$529K
Net Calls Change
+$529K